Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 FY- Text added to 2022 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
New words:
Amgen, Bachelor, bar, broadcast, cancer, carryforward, cedant, Centene, CI, conceptual, Concurrent, constrain, devised, disintermediation, dispelling, Doctor, dread, earthquake, eastern, element, elevated, endeavored, excise, forma, GMLB, Hodge, hospitalization, IASB, indeterminate, inflationary, inhibit, injured, Internet, IPO, Islamic, Khanh, Kleeman, macroeconomic, MetLife, Monsanto, Ng, noncontrolling, nonconvertible, Novation, OAS, Omnilife, organizational, outset, Papara, Pfizer, pretax, proceeding, Ray, recession, redemption, Retakaful, run, RZC, Saint, School, sought, Southern, specialist, Stewardship, struck, swaption, Takaful, TDR, toll, Topic, Tran, transferee, Turkey, unearned, Weak, weakening, wider, YRT
Valuein 2021 FY filing- Value in 2022 FY filing
Original filings
Filing view